Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price
₹10.65
Market cap
₹238.8 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-1.0×Sector 47.4×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:41 IST BSE
Annual Report

Nectar Lifesciences Annual Report

Nectar Lifesciences Ltd. has released its Annual Report for FY 2025-26. The 31st Annual General Meeting is scheduled for September 18, 2026, via video conferencing.